NSEDCP
TBPH icon

NJ State Employees Deferred Compensation Plan’s Theravance Biopharma TBPH Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$641K Hold
58,142
0.08% 237
2025
Q1
$519K Hold
58,142
0.07% 263
2024
Q4
$547K Hold
58,142
0.07% 275
2024
Q3
$469K Hold
58,142
0.06% 305
2024
Q2
$493K Hold
58,142
0.06% 283
2024
Q1
$522K Hold
58,142
0.07% 279
2023
Q4
$654K Hold
58,142
0.09% 233
2023
Q3
$502K Hold
58,142
0.08% 268
2023
Q2
$602K Hold
58,142
0.09% 237
2023
Q1
$631K Hold
58,142
0.1% 229
2022
Q4
$652K Hold
58,142
0.11% 203
2022
Q3
$590K Hold
58,142
0.1% 214
2022
Q2
$527K Hold
58,142
0.09% 249
2022
Q1
$555K Hold
58,142
0.08% 273
2021
Q4
$642K Hold
58,142
0.08% 252
2021
Q3
$431K Hold
58,142
0.06% 319
2021
Q2
$844K Hold
58,142
0.11% 199
2021
Q1
$1.19M Buy
58,142
+20,000
+52% +$408K 0.17% 137
2020
Q4
$677K Hold
38,142
0.1% 200
2020
Q3
$564K Hold
38,142
0.1% 194
2020
Q2
$801K Hold
38,142
0.15% 137
2020
Q1
$881K Hold
38,142
0.2% 114
2019
Q4
$988K Hold
38,142
0.17% 127
2019
Q3
$743K Buy
38,142
+7,000
+22% +$136K 0.14% 147
2019
Q2
$508K Hold
31,142
0.09% 252
2019
Q1
$706K Buy
31,142
+2,000
+7% +$45.3K 0.13% 155
2018
Q4
$746K Sell
29,142
-5,000
-15% -$128K 0.16% 141
2018
Q3
$1.12M Hold
34,142
0.19% 114
2018
Q2
$774K Hold
34,142
0.14% 185
2018
Q1
$828K Hold
34,142
0.15% 189
2017
Q4
$952K Buy
34,142
+10,000
+41% +$279K 0.16% 162
2017
Q3
$827K Sell
24,142
-25,142
-51% -$861K 0.15% 203
2017
Q2
$1.96M Hold
49,284
0.37% 67
2017
Q1
$1.82M Hold
49,284
0.34% 82
2016
Q4
$1.57M Hold
49,284
0.31% 100
2016
Q3
$1.79M Hold
49,284
0.37% 76
2016
Q2
$1.12M Hold
49,284
0.24% 142
2016
Q1
$1.03M Hold
49,284
0.22% 159
2015
Q4
$808K Hold
49,284
0.17% 207
2015
Q3
$541K Buy
49,284
+35,000
+245% +$384K 0.12% 263
2015
Q2
$186K Hold
14,284
0.04% 357
2015
Q1
$248K Hold
14,284
0.05% 343
2014
Q4
$214K Hold
14,284
0.04% 358
2014
Q3
$330K Hold
14,284
0.07% 323
2014
Q2
$456K Buy
+14,284
New +$456K 0.09% 305